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Since its introduction in 2004, confocal laser endomicrosco-
py (CLE) has emerged as a significant imaging tool for gas-
trointestinal endoscopic examinations. CLE is a technique 
that allows real-time in vivo microscopic imaging of the gas-
trointestinal mucosal layer.1 The CLE can obtain very high 
magnification and resolution images using the “confocal” 
method. This endomicroscopy technique enables endos-
copists to obtain real-time in vivo  histology data during an 
ongoing endoscopy procedure, thereby creating processes 
defined as “optical biopsies.”
Previously, diagnosis of IBD including CD and UC, in ad-
dition to intestinal Behçet’s disease, was primarily based 
on colonoscopic, pathological, and serological findings.2-4 
Probe-based CLE (pCLE) may be beneficial in the diagnosis 
of IBD by allowing microscopic imaging; especially in some 
cases with macroscopic mucosal healing, clinically relevant 
inflammatory changes can be visualized with CLE during 
colonoscopy.5-7 However, previous studies have mostly fo-
cused on the use of CLE in surveillance of cancer develop-
ment for IBD patients to detect intraepithelial dysplasia, and 
most of these studies regarding the CLE have focused on UC 
and not CD.5,8 Intestinal Behçet’s disease and intestinal tu-
berculosis are also known to be quite difficult to distinguish 
from CD using conventional white light endoscopy, and for 
this reason, the pathologic findings from biopsy of the lesion 
contribute substantially to the differential diagnosis. pCLE 
might represent a potential solution and may serve as an ad-
ditional diagnostic tool for determining a correct diagnosis 
of IBD.
The efficacy of pCLE in the differential diagnosis of IBD at 
an early stage has not been studied to date. Therefore, this 
study was designed to investigate the concordance of clinical 
diagnosis and pCLE findings in the differential diagnosis of 
a patient presenting with ileocecal ulcer and inflammation. 
Moreover, we compared biopsy results obtained from pCLE 
findings of the inflamed lesions to evaluate the effectiveness 
of targeted biopsies in the diagnosis of IBD. This pilot study 
includes 6 IBD patients who were subjected to pCLE per-
formed by a single gastrointestinal specialist and endosco-
pist (J.H.C) at the Severance Hospital, Seoul, South Korea.
Two UC patients were included in the study, patients A and 
B, a 45-year-old man and a 48-year-old woman, respectively. 
Patient A had been diagnosed with UC 1-year prior and 
was on maintenance treatment with balsalazide disodium, 
dehydrate 4.5 g/day. He tested negative for perinuclear anti-
neutrophil cytoplasmic antibodies (p-ANCA) initially, and 
his CRP level was 0.5 mg/L both initially and at the time 
of the pCLE procedure. Colonoscopy with pCLE was per-
formed and the colon was defined to be in the remission 
state; however, there were scar changes and a mild stricture 
at the ascending colon and hepatic flexure. The pCLE of 
the main lesion in the ascending colon showed widening 
of the lamina propria, inflammatory infiltrates, goblet cell 
depletion, and crypt distortion (Fig. 1A and B). The biopsy 
showed chronic nonspecific inflammation. pCLE was also 
performed at the normal colon mucosa of the sigmoid colon, 
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and this showed crypts disposed as straight structures ori-
ented to muscularis mucosae (Fig. 1C). Patient B had been 
diagnosed with UC, consisting of proctitis only, in 2001, and 
the disease progressed to pancolitis in 2005. She achieved 
remission in 2011 with mesalazine 2.2 g/day orally and me-
salazine enema. However, her symptoms worsened in 2013 
and the immunomodulator, azathioprine 25 mg daily was 
administrated. Azathioprine was stopped the following year, 
because the patient developed neutropenia. p-ANCA testing 
was negative and the CRP level was 0.4 mg/L at the time of 
pCLE. Colonoscopy with pCLE findings indicated the colon 
in remission, and the UC lesion in the sigmoid colon and 
rectum showed mild crypt distortion, but no dysplastic cells. 
The biopsy of this lesion showed chronic nonspecific inflam-
mation.
The next 2 patients were diagnosed with CD, and had of 
disease durations of 9 and 11 years, respectively. Patient C 
was a 44-year-old man who was diagnosed with CD in 2006 
but was not quite compliant to the treatment provided in the 
first clinic and had been under no medical care. He present-
ed at our facility in 2013 with severe abdominal pain. He had 
undergone small bowel resection owing to partial obstruc-
tion of the small bowel and a mesenteric abscess. Anti-Sac-
charomyces cerevisiae antibody (ASCA) IgG testing showed 
a positive result, and the CRP level was 76.90 mg/L. After sur-
gery, the patient was maintained on mesalazine 3 g/day and 
50 mg azathioprine maintenance therapy, with the symp-
toms being controlled and the CRP level reducing to 1.1 mg/
L. Colonoscopy with pCLE was performed and revealed a 
stricture at the ileocecal valve orifice and shallow ulcerations 
at the ileocecal valve and terminal ileum. pCLE of this main 
lesion in the terminal ileum and cecum revealed crypt de-
struction and fluorescent spillage, but a granuloma was not 
visible on pCLE (Fig. 2A and B). The pathology report of this le-
sion indicated erosion with chronic nonspecific inflammation. 
The normal mucosa of the sigmoid colon visualized by pCLE 
reveled crypts with a straight appearance, with luminal open-
ing of the crypts appearing like black holes (Fig. 2C). Patient D 
was a 29-year-old man diagnosed with CD in 2004 and was on 
mesalazine 2 g/day and 100 mg of azathioprine maintenance 
therapy. ASCA level was equivocal, and his CRP level at the 
time of pCLE was 3.1 mg/L. His colonoscopy showed multiple, 
scattered small aphthous ulcerations from the terminal ileum 
to the rectum, mostly located at the sigmoid colon and rectum 
with sparing of normal mucosa showing skipped lesions. pCLE 
of these lesions also showed crypt destruction and fluorescent 
spillage, but granuloma was not noticeable. Biopsy of both the 
terminal ileum and the sigmoid colon showed erosions with 
chronic nonspecific inflammation in both samples. 
Patient E, a 59-year-old man, was diagnosed with intestinal 
Behçet’s disease in 2002; he had undergone a total of 7 intes-
tinal resections, including right hemicolectomy and segmen-
tal resection of the transverse colon owing to the recurrence 
of intestinal Behçet’s ulcer. He was on daily 4 g of mesalazine 
and was steroid-dependent. CRP level was 12.7 mg/L at the 
time of pCLE. His colonoscopy showed huge and deep ul-
ceration at the anastomosis site, located at the ascending co-
lon. pCLE of the ulcer lesion revealed severe inflammatory 
Fig. 1. Changes of the intestinal mucosa detected by probe-based confocal laser endomicroscopy in UC (Patient A). (A) Irregular architecture and 
increased distance between the colonic crypts. (B) Leakage of fluorescein into the crypt lumen from the interstitium of the colon. (C) Normal colonic 
crypts with no fluorescein in the lumen and no crypt distortion.
A B C
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Fig. 2. Changes of the intestinal mucosa detected by probe-based confocal laser endomicroscopy in a CD (Patient C). (A, B) Ileocecal valve ulcer; crypt 
destruction, fluorescent spillage, no granuloma visible. (C) Straight appearance of crypts with luminal opening of the crypts resembling as black holes 
in the normal mucosa of sigmoid colon. 
A B C
cell infiltration and crypt destruction but granuloma, AFB, or 
vasculitis could not be observed (Fig. 3A and B). The biopsy 
taken from this lesion showed inflamed granulation tissue 
with ulceration. The normal colon mucosa of the ascend-
ing colon was also visualized and revealed normal colonic 
crypts with no fluorescein in the lumen and no crypt distor-
tion (Fig. 3C).
Patient F, a 46-year-old man, was referred to our clinic for 
further evaluation of ulcerations located at the terminal il-
eum and ileocecal valve observed at an external clinic study. 
Culture and PCR for Mycobacterium tuberculosis showed 
negative results, with negative biopsy results. The diagnosis 
of IBD was indeterminate, and pCLE was performed. pCLE 
of the ulcer site showed crypt destruction, but no granu-
loma, vasculitis, or AFB were found. The biopsy of this lesion 
showed chronic nonspecific inflammation.
In this study, we analyzed the pCLE findings of 2 UC 
patients and 2 CD patients, along with 1 Behçet’s disease 
patient and 1 patient with terminal ileal ulcer due to an un-
known cause. The study aimed to evaluate the efficacy of 
pCLE for the precise diagnosis of IBD. Confocal images were 
obtained using fluorescein as the fluorescent contrast agent. 
Allergic reactions to fluorescein, cardiovascular complica-
tions, nausea, et cetera, have been reported, but they occur 
infrequently. No adverse reactions occurred in this study.
Although several studies have reported that changes ob-
served on CLE procedures can predict long-term remission 
in IBD, those studies were not focused on the initial diag-
nosis of IBD.5,8 A precise diagnosis of IBD patient is rather 
significant, as the treatment of each disease may lead to ag-
gravation of one another. Currently, the diagnosis depends 
on a comprehensive conclusion derived from endoscopic 
findings and pathological, culture, and serological test re-
sults. Nevertheless, a 20% chance of misdiagnosis exists 
Fig. 3. Changes of the intestinal mucosa detected by probe-based confocal laser endomicroscopy in intestinal Behçet’s disease (Patient E). (A) Anas-
tomosis site ulcer; crypt destruction with disarrayed feature. (B) Abundant inflammatory cell infiltration. Granuloma, AFB, or vasculitis not visible. (C) 
Normal colonic crypts with no fluorescein in the lumen and no crypt distortion.
A B C
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and eventually the patient might have to undergo surgical 
intervention for accurate diagnosis and treatment.9 For these 
reasons, adequate tools assisting the differential diagnosis of 
IBD are desperately needed. 
Endomicroscopy is an emerging technology that provides 
a detailed microscopic analysis of the mucosal surface. His-
topathological assessment of IBD biopsies is meaningful for 
diagnosis. The guidelines for IBD management published 
by the and European Colitis and Crohn’s Organization un-
derline the essential role of pathologic examining for the 
diagnosis and definition of the type of IBD.3,10 In this context, 
endomicroscopy can be extremely advantageous, with re-
gard to simultaneously determining the location at which to 
take a biopsy sample and providing an indication of the IBD 
type during the procedure. However, an important disadvan-
tage of using CLE is the longer procedural time. Extended 
duration of colonoscopy is uncomfortable for patients and 
expensive for endoscopy wards. The price of the equipment 
adds to the increased cost of performing a CLE procedure. 
Consequently, cost–benefit studies are needed to analyze 
whether the advantages of CLE can overcome the increased 
costs of the procedure.
In our study, pCLE of UC lesions showed infiltration of in-
flammatory cells and widening of the lamina propria, crypt 
distortion, and destruction due to inflammation. These find-
ings were consistent with the diagnoses of UC and thus may 
be useful for confirming a suspected diagnosis. However, in 
CD and intestinal Behçet’s disease, pCLE could recognize 
the inflammatory cells and mucosal shedding but could not 
identify any granuloma, AFB, or vasculitis, which are signifi-
cant specific findings for diagnosis. This leads to the conclu-
sion that pCLE is of little use in the differential diagnosis of 
these diseases. Unfortunately, no intestinal tuberculosis pa-
tients were enrolled; hence, locating AFB with pCLE was not 
possible in this study. 
In conclusion, pCLE provides information on the lamina 
propria and crypt distortion and destruction due to inflam-
mation and thus may represent a useful tool for the diagno-
sis of UC. However, there are clear limitations to its use in CD 
and intestinal BD, as the presence of vasculitis or granuloma 
are not adequately visualized. Determining the exact efficacy 
of pCLE in the differential diagnosis of IBD requires further 
study, including studies in a larger cohort of IBD patients. 
Moreover, pCLE findings of intestinal tuberculosis patients, 
which were insufficient in this study, should necessarily be 
supplemented in future studies.
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